We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts
Read MoreHide Full Article
The most recent trading session ended with UnitedHealth Group (UNH - Free Report) standing at $492.11, reflecting a +0.57% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily gain of 0.07%. At the same time, the Dow lost 0.13%, and the tech-heavy Nasdaq gained 0.14%.
Shares of the largest U.S. health insurer have depreciated by 1.14% over the course of the past month, outperforming the Medical sector's loss of 1.99% and lagging the S&P 500's gain of 4.34%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on July 16, 2024. On that day, UnitedHealth Group is projected to report earnings of $6.68 per share, which would represent year-over-year growth of 8.79%. Our most recent consensus estimate is calling for quarterly revenue of $98.95 billion, up 6.51% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $27.55 per share and a revenue of $398.24 billion, demonstrating changes of +9.67% and +7.16%, respectively, from the preceding year.
It's also important for investors to be aware of any recent modifications to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.09% lower. Right now, UnitedHealth Group possesses a Zacks Rank of #3 (Hold).
From a valuation perspective, UnitedHealth Group is currently exchanging hands at a Forward P/E ratio of 17.76. This represents a premium compared to its industry's average Forward P/E of 17.13.
It's also important to note that UNH currently trades at a PEG ratio of 1.44. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As of the close of trade yesterday, the Medical - HMOs industry held an average PEG ratio of 1.22.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 204, which puts it in the bottom 20% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts
The most recent trading session ended with UnitedHealth Group (UNH - Free Report) standing at $492.11, reflecting a +0.57% shift from the previouse trading day's closing. The stock outpaced the S&P 500's daily gain of 0.07%. At the same time, the Dow lost 0.13%, and the tech-heavy Nasdaq gained 0.14%.
Shares of the largest U.S. health insurer have depreciated by 1.14% over the course of the past month, outperforming the Medical sector's loss of 1.99% and lagging the S&P 500's gain of 4.34%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. The company's earnings report is expected on July 16, 2024. On that day, UnitedHealth Group is projected to report earnings of $6.68 per share, which would represent year-over-year growth of 8.79%. Our most recent consensus estimate is calling for quarterly revenue of $98.95 billion, up 6.51% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $27.55 per share and a revenue of $398.24 billion, demonstrating changes of +9.67% and +7.16%, respectively, from the preceding year.
It's also important for investors to be aware of any recent modifications to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the company's business health and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.09% lower. Right now, UnitedHealth Group possesses a Zacks Rank of #3 (Hold).
From a valuation perspective, UnitedHealth Group is currently exchanging hands at a Forward P/E ratio of 17.76. This represents a premium compared to its industry's average Forward P/E of 17.13.
It's also important to note that UNH currently trades at a PEG ratio of 1.44. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. As of the close of trade yesterday, the Medical - HMOs industry held an average PEG ratio of 1.22.
The Medical - HMOs industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 204, which puts it in the bottom 20% of all 250+ industries.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.